FDA OK’s additional doses of Lilly’s Trulicity for type 2 diabetes

The FDA has approved two additional doses of Eli Lilly’s (NYSE:LLY) Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11.

Trulicity is a prescription medicine for adults with type 2 diabetes used to improve blood sugar and to reduce the risk of major cardiovascular events.

https://seekingalpha.com/news/3611665-fda-oks-additional-doses-of-lillys-trulicity-for-type-2-diabetes